HOME >> MEDICINE >> NEWS
It's high time we registered all clinical trials say editors of Lancet and BMJ

Time to register randomised trials

The public has a right to know what medical research is being funded, argue the editors of the Lancet and the BMJ in a joint editorial published in this week's issues. What's more, researchers and their financial backers don't want to waste resources running trials that are already being conducted elsewhere, write the authors. They claim that the solution is to make sure that all clinical trials that are underway are registered for all to see.

Dr Richard Horton, editor of the Lancet and Dr Richard Smith, editor of the BMJ write that each year a vast financial investment is made by national funding agencies, medical research charities, and drug and device manufacturers in randomised controlled trials. The problem is, they say, that the process of undertaking research is "chaotic" and "..takes little account of concurrent research".

Another area of concern, say the authors, is that researchers conducting 'systematic reviews' (a systematic review is an overview of all the original research conducted into a certain subject area) need to know about ALL the trials that have been conducted on a subject to avoid 'publication bias' (where only the positive results of trials have been recorded). By ensuring that all trials are recorded, this problem could be overcome, they say.

The difficulty in undertaking to register all clinical trials is "who will take the lead?" say Horton and Smith. There are registration initiatives already underway (such as the NHS National Research Register and the Cochrane controlled trials register) but there are others within the medical research world who have roles to play, such as editors of journals and publishers.

The most significant recent lead has been taken by the pharmaceutical industry say the authors and they note that GlaxoWellcome and Schering Health Care have committed themselves to registering clinical trials, making a commitment to "..a climate of ope
'"/>

Contact: Jill Shepherd
jshepherd@bmj.com
44-171-383-6529
BMJ-British Medical Journal
1-Oct-1999


Page: 1 2

Related medicine news :

1. British hospitals need clinical ethicists
2. Lack of clinical trial participation may contribute to lower survival rates
3. Obtaining patient consent for clinical audit is unworkable without extra resources
4. Sharing clinical trial results with participants may be beneficial
5. Two years after gene therapy treatments, severe angina patients showed prolonged clinical benefit
6. PENN begins clinical trial of newest technology to treat thoracic aortic aneurysms
7. Most episodes of HIV blips not clinically significant in patients receiving HAART
8. NIAID seeks applicants to lead clinical trials units for revamped HIV/AIDS networks
9. New non-hormonal hot flash treatment set for clinical trial
10. Study naming hospitals in top 5% for clinical quality released by HealthGrades
11. Future of clinical medicine research is at risk, warns professor

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: high time registered all clinical trials say editors Lancet and BMJ

(Date:5/24/2013)... Beach, Delaware (PRWEB) May 24, 2013 ... Mushrush has joined the Dayna Feher team at the ... Mushrush made the Delaware resorts her home in 1975. ... has since worked in all aspects of the real ... and for the past 12 years, a licensed sales ...
(Date:5/24/2013)... With Memorial Day Weekend upon us, cookout ... is offering tips to help prevent grill fires throughout the ... (NFPA) reports that gas grills led to an average ... other solid-fueled grills, meanwhile, caused approximately 1,200 home fires per ... Insurance is sharing the following tips from the NFPA to ...
(Date:5/24/2013)... -- New research suggests a link between sleep ... Every additional hour someone with insomnia sleeps ... the likelihood of moderate or high risk of ... Pennsylvania. "We were surprised by the ... suicide risk," study author, Linden Oliver, clinical research ...
(Date:5/24/2013)... Calif.) (PRWEB) May 24, 2013 ... House Appropriators and the California congressional delegation, joined ... restore sequestered industry user fees paid to the ... to ensure that future across-the-board cuts will not ... of the FY14 Agriculture, Rural Development and FDA ...
(Date:5/24/2013)... -- Drugs commonly used to treat glaucoma may cause ... with vision, according to a new study. The ... to reduce eye pressure, have already been shown to ... the researchers said, suggesting that the new findings could ... should be conservative when prescribing these drugs, the researchers ...
Breaking Medicine News(10 mins):Health News:Tammy Mushrush Joins ResortQuest Real Estate® and the Dayna Feher Team 2Health News:Don’t Get Burned: Five Grilling Tips from Amica Insurance 2Health News:Sleep Duration Linked to Suicidal Thoughts in People With Insomnia 2Health News:California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014 2Health News:California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014 3Health News:Common Glaucoma Drug May Cause Droopy Eyelids, Study Finds 2
(Date:5/23/2013)... y PARÍS, 24 de mayo de 2013 /PRNewswire/ ... destacado desarrollador y fabricante de herramientas de precisión ... y tratamiento de la enfermedad vascular periférica y ... ADVISE ( Ad enosine V asodilator ... II durante la sesión de ensayo clínico hot ...
(Date:5/23/2013)... , May 23, 2013 Amgen (NASDAQ: ... Annual  Healthcare Conference on Thursday, May 30, 2013, at ... beginning at 9:20 a.m. Eastern Daylight Time. Arvind ... will present at the conference. Live audio of the presentation ... www.amgen.com , under Investors. A replay of the webcast ...
(Date:5/23/2013)... , May 23, 2013 Nephros, Inc. ... stage medical device company that develops and sells high ... of its rights offering.  In addition, the concurrent temporary ... warrants expired on May 17, 2013. Nephros ... million from the rights offering.   A portion of the ...
Breaking Medicine Technology:Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4
Cached News: